of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2016 [Epub ahead of print]. [5] Ostronoff F, Othus M, Lazenby M, et al. Prognostic significance of… Click to show full abstract
of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2016 [Epub ahead of print]. [5] Ostronoff F, Othus M, Lazenby M, et al. Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report. J Clin Oncol. 2015;33:1157–1164. [6] Guolo F, Minetto P, Clavio M, et al. High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: a critical review of a 10-year, single-center experience in younger, non M3 AML patients. Am J Hematol. 2016;91:755–762.
               
Click one of the above tabs to view related content.